Surgical Oncologists Team Led by Dr. Vinay Samuel Gaikwad Becomes First In Gurugram To to Perform PIPAC For Advanced Abdominal Cancers

Dr. Vinay Samuel Gaikwad Becomes First In Gurugram To Perform PIPAC

Gurugram (Haryana) [India], July 12 (ANI): Paras Hospital in Gurugram became the first in the city to perform Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) on a patient who had run out of options after her ovarian cancer recurred for the third time.

A 35-year-old Rupshikha Thakur (name changed), whose body had stopped responding to traditional treatment after undergoing cycles of strenuous chemotherapy, targeted therapy, and immunotherapy, became the first to undergo the procedure in the millennium city under the expert team of surgical oncologists led by Dr. Vinay Samuel Gaikwad, Associate Director, Surgical Oncology, Paras Cancer Centre.

Dr. Vinay Samuel Gaikwad

Dr. Vinay said that PIPAC is a palliative option of treatment for patients suffering from ovarian, gastric, colorectal, appendicular, and certain other cancers which have spread within the abdomen.

“The PIPAC process is a combination of surgery and chemotherapy. This is a laparoscopic procedure in which a keyhole (incision) is made. Using a special device, standard liquid chemotherapy that has been converted into gaseous/aerosol form is sprayed directly onto the cancerous area. After the procedure, the residual fumes are absorbed through a special filter and the incision is closed. I

n fact, after the procedure, the patient can be discharged on the same day or the next,” Dr. Vinay said.
What makes this procedure unique is that it can be used when other treatment fails. Also, the patient’s general condition does not have to be very good in order to tolerate the procedure.

“Side-effects that are commonly seen in other procedures such as hair loss, kidney problems, liver problems, vomiting etc, are either minimal or not seen at all. Any patient with peritoneal cancer, who can withstand a two-hour surgery under anesthesia, is compatible with this therapy. Therefore, most patients can tolerate this procedure very well,” he said. (ANI)

Disclaimer: The views expressed in the article above are those of the authors’ and do not necessarily represent or reflect the views of this publishing house. Unless otherwise noted, the author is writing in his/her personal capacity. They are not intended and should not be thought to represent official ideas, attitudes, or policies of any agency or institution.

Sources: Business World, Times of Republic,

Leave a Reply

Your email address will not be published. Required fields are marked *